Nemocnice s poliklinikou v Moste

Most 434 64

0 studies enrolling now · 2 studies all time

What they study most

Influenza, Respiratory Syncytial Virus Infections

Studies at this site

• Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age — Completed
• Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children — Completed